FolioLantern
CPRTCopart · Insider ownership research

Copart insiders sold $9.9M in the past 12 months. How much of their stake is that?

About 0.1% overall. As a group they still hold 100.0% of their starting shares. The biggest individual seller, Thomas Tryforos, gave up 23% of starting holdings.

Updated Oct 8, 2026 from SEC filings · covers Oct 9, 2025 to Oct 8, 2026
How this comparesMore of their stake sold than at 36 of the 311 other companies we can measure (#276 of 312)See ranking
0
buyers among officers and directors, past 12 months
29%
of sales were under disclosed trading plans, past 12 months
3 of 15
officers and directors sold shares, past 12 months
Recent activity · past 30 days, Sep 9, 2026 to Oct 8, 2026

No officer or director trades were reported for the past 30 days. The most recent before that:

Jul 28, 2026Jeffrey Liaw sold 28K shares ($846K) under a disclosed trading plan. 47K shares came in from vesting or option exercises the same day, so the holding rose by 19K net.
WhoSharesPrice% of total stakeTotal stake afterTrade dateFiled
Jeffrey Liaw
Chief Executive Officer
27,745$30.49n/an/aJul 28, 2026Jul 30, 2026

"% of total stake" is the shares in this event against all the vested shares the person held that day, across every share class and holding entity, after that day's vesting. "n/a" means the person's holdings don't reconcile, or the row is a purchase. "Holdings record incomplete" means more shares were sold than the filings show the person held that day, so a percentage would be wrong.

Is this normal? Less than usual: about one-tenth of the 5-year average. 3 insiders sold; the average is 6 a year. Year by year
Latest filing: Filed Jul 30 for a sale on Jul 28. Jeffrey Liaw sold 28K shares ($846K) under a disclosed plan. Filing
27 SEC ownership filings in the period · See the evidence

What stands out

Two directors sold $6.1M with no disclosed plan: Thomas Tryforos ($3.9M, 23% of holdings) and Daniel Englander ($2.2M). The filings don't state a reason.Thomas Tryforos: largest such sale, Nov 25, 2025 · Daniel Englander: largest such sale, Jul 13, 2026

Percentages cover 5 of 15 officers and directors. 10 are left out

i
Left out: Daniel Englander and Jeffrey Liaw (holdings couldn't be fully reconciled); James Meeks (most holdings were last confirmed in 2004); Steven Cohan (most holdings were last confirmed in 2021); Matt Blunt, Stephen Fisher, Cherylyn LeBon, Carl Sparks, Leah Stearns and David Berger (held no vested shares at the start).
Disclosed company stock is not an insider's whole wealth.

Who sold, and how much of their stake

Officers and directors, past 12 months. Each bar is the insider's vested stake at the start of the period (Oct 8, 2025). The gold part is what they sold.

SoldRest of starting stakeAdded during the period
Thomas Tryforos
Director
23% · $3.9MNo plan disclosed
Jeffrey Liaw
Chief Executive Officer
No bar: holdings couldn't be fully reconciled.
$3.8M76% planned
Daniel Englander
Director
No bar: holdings couldn't be fully reconciled.
$2.2MNo plan disclosed
Amounts, filings and trading plans for each seller

Selling by month

Officers and directors, Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

Disclosed planTo cover taxesNo plan disclosed
Oct 2025: $1.1M under a disclosed planOctNov 2025: $3.9M no plan disclosed$3.9MNovDecJan 2026: $98K under a disclosed planJan 2026: $912K no plan disclosedJanFebMarApr 2026: $870K under a disclosed planAprMayJunJul 2026: $846K under a disclosed planJul 2026: $2.2M no plan disclosedJulAugSepOct

Common questions

Is the Copart CEO selling stock?

Yes. Jeffrey Liaw sold 103K shares ($3.8M) in the past 12 months, 76% of it under a trading plan disclosed in the filings.

Why are Copart insiders selling?

Filings rarely give a reason, and we don't guess at one. What they show is how the sales were made: 29% of sales by value ran under 10b5-1 trading plans disclosed in the filings and 71% had no disclosed plan. A trading plan schedules sales in advance.

Are any Copart insiders buying?

No. Officers and directors reported no purchases in the past 12 months.

How much of their stake did Copart insiders sell?

About 0.1% overall. As a group they still hold 100.0% of their starting shares. The biggest individual seller, Thomas Tryforos, gave up 23% of starting holdings. That covers the 12 months to Oct 8, 2026 and counts vested shares reported on SEC Forms 3, 4 and 5, which is not an insider's whole wealth.

The evidence

Who sold3 officers and directors: amount, % of holdings, trading plan
Who soldAmount% of holdingsTrading plan
Thomas Tryforos
Director
$3.9M
100K shares
23%No plan disclosed
Jeffrey Liaw
Chief Executive Officer
$3.8M
103K shares
i
No percentage: holdings couldn't be fully reconciled.
76% under a disclosed plan
Daniel Englander
Director
$2.2M
80K shares
i
No percentage: holdings couldn't be fully reconciled.
No plan disclosed
The full ownership picture13 of 15 insiders fully reconciled · 7 officers and directors

Vested shares across all share classes, held directly and through trusts, LLCs and family members, as reported on SEC Forms 3, 4 and 5. Unvested awards and options are never counted as owned shares.

InsiderHeld Oct 8, 2025SoldHeld Oct 8, 2026Still held
Willis Johnson
i
Additional holdings last reported more than 3 years ago are shown separately and excluded from totals.
Chairman of the Board, Director
55.61M055.61Mno sales
Vesting, gifts, unvested awards and holding lines for Willis Johnson
0shares vested or exercised
0gifted (net of own trusts)
none reportedunvested awards, start → end
  • Additional holdings last reported more than 3 years ago are shown separately and excluded from totals.
Held throughShare classOct 8, 2025Oct 8, 2026
DirectCommon Stock3,547,6643,547,664
Willis J. Johnson and Reba J. Johnson Revocable Trust DTD 1/16/1997Common Stock50,681,96350,681,963
Willis and Reba's FoundationCommon Stock1,385,0491,385,049

Additional holdings last reported Jun 27, 2023, not confirmed since: 33,732,236 shares. Not included in any total or percentage on this page.

Stock options (not counted as shares):

Options heldStrike priceExpiresIntrinsic value (estimate)
14,084$47.39Dec 8, 2030$0
11,183$62.08Dec 6, 2031$0
17,813$38.72Dec 5, 2032$0

Estimate: options held × ($30.49 − strike price), using the most recent insider trade price on Form 4 (Jul 28, 2026), not a market close.

Jayson Adair
i
Additional holdings last reported more than 3 years ago are shown separately and excluded from totals.
Executive Chairman, Director
26.56M026.51Mno sales
Vesting, gifts, unvested awards and holding lines for Jayson Adair
0shares vested or exercised
−50Kgifted (net of own trusts)
none reportedunvested awards, start → end
  • Additional holdings last reported more than 3 years ago are shown separately and excluded from totals.
Held throughShare classOct 8, 2025Oct 8, 2026
A. Jayson Adair and Tammi L. Adair Revocable TrustCommon Stock14,182,62014,174,859
JTGJ Investments II, LPCommon Stock8,000,0008,000,000
Adair FoundationCommon Stock1,920,0001,920,000
JTGJ Investments, LPCommon Stock1,839,3121,839,312
2018 Willis and Reba Johnson Irrevocable Trust B, UAD 12/21/2018Common Stock339,200318,000
2018 Willis and Reba Johnson Irrevocable Trust A, UAD 12/21/2018Common Stock275,600254,400
JTGJ Properties, LPCommon Stock5,0005,000

Additional holdings last reported Sep 15, 2021, not confirmed since: 7,758,960 shares. Not included in any total or percentage on this page.

Thomas Tryforos
i
An owner entity could not be identified from the footnotes.
Director
442K−100K442K100%
Vesting, gifts, unvested awards and holding lines for Thomas Tryforos
+100Kshares vested or exercised
0gifted (net of own trusts)
none reportedunvested awards, start → end
  • An owner entity could not be identified from the footnotes.
Held throughShare classOct 8, 2025Oct 8, 2026
DirectCommon Stock00
Unresolved (see footnote)Common Stock441,635413,785
Grand Street FoundationCommon Stock027,850

Stock options (not counted as shares):

Options heldStrike priceExpiresIntrinsic value (estimate)
14,084$47.39Dec 8, 2030$0
11,183$62.08Dec 6, 2031$0
17,813$38.72Dec 5, 2032$0

Estimate: options held × ($30.49 − strike price), using the most recent insider trade price on Form 4 (Jul 28, 2026), not a market close.

Daniel Englander
!
Holdings couldn't be fully reconciled. Balance changed without a matching transaction, and the footnote does not state the amount: +175,752 shares on Jul 13, 2026 (Ursual Capital Partners). See the filing Sales and other transactions for Daniel Englander are complete.
Director
n/a−80Kn/an/a
Vesting, gifts, unvested awards and holding lines for Daniel Englander
+100Kshares vested or exercised
0gifted (net of own trusts)
none reportedunvested awards, start → end
  • Starting holdings restated for a probable stock split.
  • Additional holdings last reported more than 3 years ago are shown separately and excluded from totals.

Holdings couldn't be fully reconciled. Balance changed without a matching transaction, and the footnote does not state the amount: +175,752 shares on Jul 13, 2026 (Ursual Capital Partners). The balances below are as reported, not verified totals.

Held throughShare classOct 8, 2025Oct 8, 2026
DirectCommon Stock0100,000
Ursual Capital PartnersCommon Stock179,600235,352

Additional holdings last reported Jan 5, 2021, not confirmed since: 37,400 shares. Not included in any total or percentage on this page.

Stock options (not counted as shares):

Options heldStrike priceExpiresIntrinsic value (estimate)
14,084$47.39Dec 8, 2030$0
320,000$4.56Dec 3, 2024$8.3M
11,183$62.08Dec 6, 2031$0
17,813$38.72Dec 5, 2032$0

Estimate: options held × ($30.49 − strike price), using the most recent insider trade price on Form 4 (Jul 28, 2026), not a market close.

Jeffrey Liaw
!
Holdings couldn't be fully reconciled. Balance changed with no matching transaction and no footnote: -25,687 shares on Oct 15, 2025 (Direct). See the filing Sales and other transactions for Jeffrey Liaw are complete.
Chief Executive Officer
n/a−103Kn/an/a
Vesting, gifts, unvested awards and holding lines for Jeffrey Liaw
+198Kshares vested or exercised
0gifted (net of own trusts)
none reportedunvested awards, start → end

Holdings couldn't be fully reconciled. Balance changed with no matching transaction and no footnote: -25,687 shares on Oct 15, 2025 (Direct). The balances below are as reported, not verified totals.

Held throughShare classOct 8, 2025Oct 8, 2026
DirectCommon Stock31,52799,641

Stock options (not counted as shares):

Options heldStrike priceExpiresIntrinsic value (estimate)
21,332$6.78Oct 10, 2026$506K
355,557$8.70Oct 4, 2027$7.7M
4,868$6.78Oct 10, 2026$115K
222,696$8.70Oct 4, 2027$4.9M
221,884$6.78Oct 10, 2026$5.3M
182,718$8.70Oct 4, 2026$4.0M
178,718$8.70Oct 4, 2027$3.9M

Estimate: options held × ($30.49 − strike price), using the most recent insider trade price on Form 4 (Jul 28, 2026), not a market close.

Diane Morefield
Director
20K070Kno sales
Vesting, gifts, unvested awards and holding lines for Diane Morefield
+50Kshares vested or exercised
0gifted (net of own trusts)
none reportedunvested awards, start → end
Held throughShare classOct 8, 2025Oct 8, 2026
DirectCommon Stock050,000
Diane Molinari Morefield Irrevocable TrustCommon Stock20,00020,000

Stock options (not counted as shares):

Options heldStrike priceExpiresIntrinsic value (estimate)
14,084$47.39Dec 8, 2030$0
11,183$62.08Dec 6, 2031$0
50,000$19.38Jul 20, 2026$556K
17,813$38.72Dec 5, 2032$0

Estimate: options held × ($30.49 − strike price), using the most recent insider trade price on Form 4 (Jul 28, 2026), not a market close.

Jane Pocock
i
Started reporting during the period; starting holdings are from the Form 3.
President
3300330no sales
Vesting, gifts, unvested awards and holding lines for Jane Pocock
0shares vested or exercised
0gifted (net of own trusts)
90K → 115Kunvested awards, start → end
  • Started reporting during the period; starting holdings are from the Form 3.
Held throughShare classOct 8, 2025Oct 8, 2026
DirectCommon Stock330330

Stock options (not counted as shares):

Options heldStrike priceExpiresIntrinsic value (estimate)
500,000$31.61Aug 13, 2036$0

Estimate: options held × ($30.49 − strike price), using the most recent insider trade price on Form 4 (Jul 28, 2026), not a market close.

13 of 15 insiders fully reconciled: starting holdings plus reported transactions match ending holdings (13 exactly, 0 with a minor or footnoted difference). For 2 we show sales but not holdings; the ! icon on their rows explains why. Percentages cover 5 of 15 officers and directors. Left out: Daniel Englander and Jeffrey Liaw (holdings couldn't be fully reconciled); James Meeks (most holdings were last confirmed in 2004); Steven Cohan (most holdings were last confirmed in 2021); Matt Blunt, Stephen Fisher, Cherylyn LeBon, Carl Sparks, Leah Stearns and David Berger (held no vested shares at the start). "Still held" compares ending with starting vested shares; a plus sign means the holding grew.

What explains the selling$9.9M of sales by plan status, purpose, seller and month

Officer and director open-market sales: $9.9M across 283,378 shares. Plan status and stated purpose are separate questions, and a sale can have both.

By plan status

The lighter segment is sales with no plan disclosed in the filing ($7.0M), including tax-related sales outside a plan.

No plan disclosed · $7.0M

Sales with no 10b5-1 plan and no tax reference in the filing. $3.9M of it is Thomas Tryforos. No plan disclosed is a statement about the filing, not about why the sale happened. Largest such sale: Thomas Tryforos, Nov 25, 2025

SellerShares soldProceedsUnder a disclosed planShare of totalSales dates
Thomas Tryforos
Director
100K$3.9M0%39%Nov 25, 2025 to Nov 25, 2025
Jeffrey Liaw
Chief Executive Officer
103K$3.8M76%38%Oct 15, 2025 to Jul 28, 2026
Daniel Englander
Director
80K$2.2M0%22%Jul 13, 2026 to Jul 13, 2026

Sales by month

MonthSale proceedsDisclosed planTo cover taxesNo plan disclosed
Oct 2025$1.1M$1.1M$0$0
Nov 2025$3.9M$0$0$3.9M
Dec 2025$0$0$0$0
Jan 2026$1.0M$98K$0$912K
Feb 2026$0$0$0$0
Mar 2026$0$0$0$0
Apr 2026$870K$870K$0$0
May 2026$0$0$0$0
Jun 2026$0$0$0$0
Jul 2026$3.0M$846K$0$2.2M
Aug 2026$0$0$0$0
Sep 2026$0$0$0$0
Oct 2026$0$0$0$0
Is this normal? Selling year by year5 earlier years to compare with

Less than usual: about one-tenth of the 5-year average. 3 insiders sold; the average is 6 a year.

12 months endingShares soldInsiders who soldProceeds
Oct 8, 2026
Latest 12 months
283K3$9.9M
Oct 8, 2025
1 year earlier
6.43M8$83.2M
Oct 8, 2024
2 years earlier
1.41M5$75.6M
Oct 9, 2023
3 years earlier
3.06M7$135M
Oct 9, 2022
4 years earlier
340K3$21.6M
Oct 9, 2021
5 years earlier
3.80M7$233M

Open-market sales (Form 4 code S) by people who were officers or directors, in split-adjusted shares. Earlier years include people who have since left. A sale that an outside holder also reports (a family trust, a fund) is counted with outside holders in every year. Shares, not dollars, are compared, so a change in the stock price doesn't look like a change in selling. Years the filings don't fully cover are shown but left out of the average.

Known gaps and uncertainty2 insiders whose holdings couldn't be fully reconciled

Daniel Englander: holdings couldn't be fully reconciled (difference of 175,752 shares). Balance changed without a matching transaction, and the footnote does not state the amount: +175,752 shares on Jul 13, 2026 (Ursual Capital Partners). Filing, Jul 13, 2026

Footnote: "The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.50 to $27.66, inclusive. The reporting person undertakes to provide to Copart, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. | Includes 275,352 shares held by Ursula Capital Partners, for which Mr. Englander serves as the sole general partner."

Jeffrey Liaw: holdings couldn't be fully reconciled (difference of -26,679 shares). Balance changed with no matching transaction and no footnote: -25,687 shares on Oct 15, 2025 (Direct). Filing, Oct 15, 2025

Inferred rename: "Lequeita Family Limited Partnership" is treated as the same holder as "Lequeita Family Limited Partership", because the old name was never reported again and the new one opened with the same balance (283,728 shares). Old name, new name

Inferred rename: "Wilis Johnson and Joyce Johnson Family Limited Partnership" is treated as the same holder as "Willis Johnson and Joyce Johnson Family Limited Partnership", because the old name was never reported again and the new one opened with the same balance (9,179,280 shares). Old name, new name

Inferred rename: "an irrevocable trust for the benefit of a member of Mr" is treated as the same holder as "Immediate family", because the old name was never reported again and the new one opened with the same balance (49,392 shares). Old name, new name

Inferred rename: "Ursula Capital Partners" is treated as the same holder as "Ursual Capital Partners", because the old name was never reported again and the new one opened with the same balance (275,352 shares). Old name, new name

Inferred rename: "Prescott Investors Inc. Profit Sharing Trust" is treated as the same holder as "Prescott Investors Profit Sharing Trust", because the old name was never reported again and the new one opened with the same balance (1,737,600 shares). Old name, new name

Inferred rename: "Prescott International Partners L.P" is treated as the same holder as "Prescott International Partners", because the old name was never reported again and the new one opened with the same balance (604,136 shares). Old name, new name

External context: we only cite outside events when a documented connection exists. None is shown for this period.

Sources and methodology735 filings from SEC EDGAR, and how we read them

All 735 Forms 3, 4 and 5 filed for Copart (SEC CIK 900075) from Aug 21, 2003 to Aug 18, 2026, retrieved from SEC EDGAR on Oct 8, 2026. Prices are the ones reported in each filing, often weighted averages.

Probable 2-for-1 stock split on or before Mar 23, 2012 (split date stated in a footnote). Splits aren't reported as transactions; 6 holding lines changed by exactly this ratio, so earlier share counts are restated.

Probable 2-for-1 stock split on or before Apr 3, 2017 (split date stated in a footnote). Splits aren't reported as transactions; 9 holding lines changed by exactly this ratio, so earlier share counts are restated.

Probable 2-for-1 stock split on or before Sep 19, 2023 (first filing that shows post-split balances). Splits aren't reported as transactions; 6 holding lines changed by exactly this ratio, so earlier share counts are restated.

Holdings. Each holding line (a share class plus an owner, such as a trust or LLC) carries its last reported balance forward. Entities first reported during the period start at zero, so transfers between an insider's own trusts don't count as selling. Lines not reported for three years or more are listed separately and left out of totals.

Sales. A sale counts as under a 10b5-1 plan if its footnote cites one or the filing's Rule 10b5-1 box is checked, and as tax-related if its footnote cites tax obligations or sell-to-cover. Shares withheld by the company for taxes are listed separately. Sales with neither attribute are labeled "no plan disclosed".

Full methodology

Former or inactive filers (28)No filing in 18 months; last reported balances, not in any total
NameLast filedLast reported balance
John NorthMar 11, 2021No balance on record
William FranklinJul 16, 201935,934 shares, last reported balance as of Jul 15, 2019
Vincent MitzOct 2, 2017554,080 shares, last reported balance as of Sep 28, 2017
Vikrant BhatiaDec 22, 201612,724 shares, last reported balance as of Dec 20, 2016
Sean EldridgeSep 27, 20163,328 shares, last reported balance as of Sep 23, 2016
Robert VannucciniJul 15, 201614,468 shares, last reported balance as of Jul 14, 2016
Paul StyerJul 6, 2016709,672 shares, last reported balance as of Jul 5, 2016
John LindleJul 13, 201557,400 shares, last reported balance as of Jun 13, 2013
Rama PrasadJul 13, 201522,700 shares, last reported balance as of Oct 9, 2014
Bruce BishopMar 11, 20154,000 shares, last reported balance as of Sep 25, 2014
Matthew BurgenerJun 5, 2014No balance on record
Justin ChapmanApr 22, 2014No balance on record
Simon RoteJan 16, 2014281,080 shares, last reported balance as of Apr 10, 2013
Vincent PhillipsJan 16, 2014No balance on record
Anthony CristelloJan 16, 2014No balance on record
Russell LowyMar 18, 2013No balance on record
Thomas WylieNov 30, 20126,892 shares, last reported balance as of Nov 29, 2012
David JohnsonJul 27, 2011No balance on record
David BauerMar 14, 2011494,640 shares, last reported balance as of Mar 10, 2011
Thomas SmithDec 13, 201031,547,632 shares, last reported balance as of Mar 22, 2010
Soren MillsApr 21, 2010No balance on record
Greg TuckerMar 22, 201016,000 shares, last reported balance as of Mar 19, 2010
Barry RosensteinMar 17, 20094,839,176 shares, last reported balance as of Mar 17, 2009
James GrosfeldJul 5, 200734,400,000 shares, last reported balance as of Jul 2, 2007
Harold BlumensteinDec 28, 20064,404,224 shares, last reported balance as of Dec 27, 2006
Jonathan VanniniJun 8, 2006No balance on record
Gerald WatersJul 13, 2005161,784 shares, last reported balance as of Jul 12, 2005
Marvin SchmidtDec 15, 200410,498,600 shares, last reported balance as of Dec 14, 2004